Combined effects of angiostatin and ionizing radiation in antitumour therapy

Nature

Volumn 394, Issue 6690, 1998, Pages 287-291

  Mauceri, Helena J ^a   Hanna, Nader N ^a   Beckett, Michael A ^a   Gorski, David H ^a   Staba, Mary Jane ^a   Stellato, Kerri Anne ^a   Bigelow, Kevin ^a   Heimann, Ruth ^a   Gately, Stephen ^b   Dhanabal, Mohanraj ^c   Soff, Gerald A ^b   Sukhatme, Vikas P ^c   Kufe, Donald W ^d   Weichselbaum, Ralph R ^a  

^a UNIVERSITY OF CHICAGO   (United States)

^b NORTHWESTERN UNIVERSITY   (United States)

^c BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^d HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOSTATIN; PLASMINOGEN; RECOMBINANT ANGIOSTATIN; UNCLASSIFIED DRUG;

ANGIOGENESIS; ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER INHIBITION; CONTROLLED STUDY; CYTOTOXICITY; FEMALE; IONIZING RADIATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; RADIATION DOSE; RADIOSENSITIVITY; TUMOR; TUMOR GROWTH; TUMOR VASCULARIZATION; TUMOR VOLUME;

ANIMALIA;

EID: 18244419396     PISSN: 00280836     EISSN: None     Source Type: Journal    
DOI: 10.1038/28412     Document Type: Article

References (16)

1. Folkman, J. & Shing, Y. Angiogenesis. J. Biol. Chem. 267, 10931-10934 (1992).
2. Fidler, I. J. & Ellis, L. M. The implications of angiogenesis for the biology and therapy of cancer metastasis. Cell 79, 185-188 (1994).
3. Folkman, J. Angiogenesis in cancer, vascular, rheumatoid and other disease. Nature Med. 1, 27-31 (1995).
4. Hanahan, D. & Folkman, J. Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. J. Natl Cancer Inst. 88, 1091-1092 (1996).
5. Rak, J. W., St Croix, B. D. & Kerbel, R. S. Consequences of angiogenesis for tumor progression, metastasis and cancer therapy. Anticancer Drugs 6, 3-18 (1995).
6. Cao, Y. et al. Kringle domains of human angiostatin. Characterization of the anti-proliferative activity on endothelial cells. J. Biol. Chem. 271, 29461-29467 (1996).
7. O'Reilly, M. Angiostatin: a novel angiogenesis inhibitor that mediates the suppression of metastases by a Lewis lung carcinoma. Cell 79, 315-328 (1994).
8. O'Reilly, M., Holmgren, L., Chen, C. & Folkman, J. Angiostatin induces and sustains dormancy of human primary tumors in mice. Nature Med. 2, 689-692 (1996).
9. Holmgren, L., O'Reilly, M. S. & Folkman, J. Dormancy of micrometastases: balanced proliferation and apoptosis in the presence of angiogenesis suppression. Nature Med. 1, 149-153 (1995).
10. Sim, B. K. et al. A recombinant human angiostatin protein inhibits experimental primary and metastatic cancer. Cancer Res. 57, 1329-1334 (1997).
11. Weichselbaum, R. R. et al. Radiation-resistant and repair-proficient human tumor cells may be associated with radiotherapy failure in head- and neck-cancer patients. Proc. Natl Acad. Sci. USA 83, 2684-2688 (1986).
12. Weichselbaum, R. R., Beckett, M. A., Dahlberg, W. & Dritschilo, A. Heterogeneity of radiation response of a parent human epidermoid carcinoma cell line and four clones. Int. J. Radiat. Oncol. Biol. Phys . 14, 907-912 (1988).
13. Kerbel, R. S. Inhibition of tumor angiogenesis as a strategy to circumvent acquired resistance to anti-cancer therapeutic agents. BioEssays 13, 31-36 (1991).
14. Kakeji, Y. & Teicher, B. A. Preclinical studies of the combination of angiogenic inhibitors with cytotoxic agents. Invest. New Drugs 15, 39-48 (1997).
15. Teicher, B. A., Sotomayor, E. A. & Huang, Z. D. Antiangiogenic agents potentiate cytotoxic cancer therapies against primary and metastatic disease. Cancer Res. 52, 6702-6704 (1992).
16. Gately, S. et al. The mechanism of cancer-mediated conversion of plasminogen to the angiogenesis inhibitor angiostatin. Proc. Natl Acad. Sci. USA 94, 10868-10872 (1997).